Simplex Trading
CSBR icon

Simplex Trading’s Champions Oncology CSBR Stock Holding History

Simplex Trading’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-113
Closed -$569 – 8664
2024
Q3 		$0 Sell
113
-2,891
-96% -$13.6K ﹤0.01% 8635
2024
Q2 		$15K Buy
3,004
+1,407
+88% +$6.86K ﹤0.01% 7117
2024
Q1 		$7K Buy
+1,597
New +$9.35K ﹤0.01% 7811
2023
Q4 		– Sell
-1,064
Closed -$6K – 8922
2023
Q3 		$6K Buy
+1,064
New +$6.72K ﹤0.01% 7511
2022
Q4 		– Sell
-94
Closed – – 9359
2022
Q3 		$0 Hold
94
– – ﹤0.01% 10033
2022
Q2 		$0 Buy
+94
New +$719 ﹤0.01% 10103

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Simplex Trading's CSBR Position: Q4 2024 in Review

Simplex Trading sold out of Champions Oncology (CSBR) in Q4 2024, closing a stake of 113 shares — an estimated $569 sold.

Simplex Trading first reported a position in CSBR in Q2 2022 and held it in 6 quarters. The position peaked at $15K in Q2 2024. 25 funds tracked by Wall St. Rank hold CSBR as of Q4 2024.

  • Simplex Trading reported no remaining Champions Oncology position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 113 Champions Oncology shares in Q4 2024, an estimated $569.
  • Simplex Trading first reported a position in Champions Oncology in Q2 2022 and held it in 6 quarters.
  • Simplex Trading's Champions Oncology position peaked at $15K in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.